Effect of hormone replacement therapy on CD4+ and CD8 + numbers, CD4+/CD8+ ratio, and immunoglobulin levels in hemodialysis patients

Renal Failure

Volumn 27, Issue 4, 2005, Pages 421-424

  Dogan, Ekrem ^a   Erkoc, Reha ^a   Demir, Cengiz ^a   Sayarlioglu, Hayriye ^a   Dilek, Imdat ^a   Sayarlioglu, Mehmet ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

CD4+; CD4+ CD8+; CD8+; Hemodialysis; Hormone replacement therapy; Immunoglobulin

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; ESTRADIOL; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; TRISEQUENS;

ADULT; ARTICLE; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; EARLY MENOPAUSE; ESTROGEN DEFICIENCY; FEMALE; HELPER CELL; HEMODIALYSIS; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNE STATUS; IMMUNOGLOBULIN BLOOD LEVEL; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; PRIORITY JOURNAL; SUPPRESSOR CELL; UREMIA;

ADULT; ANTIGENS, CD4; ANTIGENS, CD8; BIOLOGICAL MARKERS; CD4-CD8 RATIO; COHORT STUDIES; EVALUATION STUDIES; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; KIDNEY FAILURE, CHRONIC; MENOPAUSE; MIDDLE AGED; PROGNOSIS; RENAL DIALYSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 22244482808     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-65342     Document Type: Article

References (19)

1. Zingraff, J.; Jungers, P.; Pellisier, C.; Nahoul, K.; Feinstein, M.C.; Scholler, R. Pituitary and ovarian dysfunctions in women on hemodialysis. Nephron 1982, 30, 149-153.
2. Mantouvalos, H.; Metallinos, C.; Makrygiannakis, A.; Gouskes, A. Sex hormones in women on hemodialysis. Int. J. Gynaecol. Obstet. 1984, 22, 367-370.
3. Hussein, M.M.; Mooij, M.J.; Roujouleh, H. Tuberculosis and chronic renal disease. Semin. Dial. 2003, 1, 38-44.
4. Cutolo, M.; Sulli, A.; Seriolo, B.; Accardo, S.; Masi, A.T. Estrogens, the immune response and autoimmunity. Clin. Exp. Rheumatol. 1995, 13, 217-226.
5. Tzanno-Martins, C.; Futata, E.; Jorgetti, V.; Duarte, A.J.S. Restoration of impaired T-cell proliferation after parathyroidectomy in hemodialysis patients. Nephron 2000, 84, 224-227.
6. Chan, T. Y. Vitamin D deficiency and susceptibility to tuberculosis. Calcif. Tissue Int. 2000, 66, 468-476.
7. Brunelli, R.; Frasca, D.; Perrone, G.; Pioli, C.; Fattorossi, A.; Zichella, L.; Doria, G. Hormone replacement therapy affects various immune cell subsets and natural cytotoxicity. Gynecol. Obstet. Invest. 1996, 41, 128-131.
8. Inman, R.D. Immunologic sex differences and the female predominance in systemic lupus erythematosus. Arthritis Rheum. 1978, 21, 849-852.
9. Caulin-Glaser, T.; Farrell, W.J.; Pfau, S.E.; et al. Modulation of circulating cellular adhesion molecules in postmenopausal women with coronary artery disease. J. Am. Coll. Cardiol. 1998, 31, 1555-1560.
10. Giglio, T.; Imro, M.A.; Filaci, G.; Scudeletti, M.; Puppo, F.; Cecco, L.D. Immune cell circulating subsets are affected by gonadal function. Life Sci. 1994, 54, 1305-1312.
11. Deshpande, R.R.; Chang, M.Y.; Chapman, J.C.; Michael, S.D. Alteration of cytokine production in follicular cystic ovaries induced in mice by neonatal estradiol injection. Am. J. Reprod. Immunol. 2000, 44, 80-88.
12. Evans, M.J.; MacLaughlin, S.; Marvin, R.D.; Abdou, N.I. Estrogen decreases in vitro apoptosis of peripheral blood mononuclear cells from women with normal menstrual cycles and decreases TNF-α production in SLE but not in normal cultures. Clin. Immunol. Immunopathol. 1997, 82, 258-262.
13. Porter, V.R.; Greendale, G.A.; Schocken, M.; Zhu, X.; Effros, R.B. Immune effects of hormone replacement therapy in post-menopausal women. Exp. Gerontol. 2001, 36, 311-326.
14. Miller, L.; Hunt, J.S. Sex steroid hormones and macrophage function. Life Sci. 1996, 59, 1-14.
15. Kohen, F.; Abel, L.; Sharp, A.; et al. Estrogen-receptor expression and function in thymocytes in relation to gender and age. Dev. Immunol. 1998, 5, 277-285.
16. Besedovsky, H.O.; Sorkin, E. Thymus involvement in female sexual maturation. Nature 1974, 249, 356-358.
17. Yang, J.H.; Chen, C.D.; Wu, M.Y.; Chao, K.H.; Yang, Y.S.; Ho, H.N. Hormone replacement therapy reverses the decrease in natural killer cytotoxicity but does not reverse decrease in the T-cell subpopulation or interferon-gamma production in postmenopausal women. Fertil. Steril. 2000, 72, 261-267.
18. Holl, M.; Donat, H.; Weise, W. Peripheral blood lymphocyte subpopulation of postmenopause replacement theraphy. Zentralblatt 2001, 123, 543-545.
19. Yilmazer, M.; Fenkci, F.; Aktepe, O.; Sonmezer, M.; Kurtay, G. Association of serum immunoglobulin (IgG,Ig) levels with hormone replacement therapy in healthy post-menopausal woman. Hum. Reprod. 2003, 18, 1531-1535.